Literature DB >> 3609757

Fluorescein and fluorescein glucuronide in the vitreous body of diabetic patients.

H Lund-Andersen, M Larsen, P Dalgaard, W Olsen.   

Abstract

Fluorescein (F) and fluorescein glucuronide (FG) were determined in the vitreous of four diabetic patients by a double-filter slit-lamp fluorophotometric technique. Determinations were performed 60-80 min after i.v. injection of fluorescein. F and FG were also determined in plasma ultrafiltrate 5, 15, 30, 60 and 120 min after injection by high-pressure liquid chromatography. The concentration of FG in the vitreous was 3 times that of F. After correction for plasma concentrations of FG higher than those of F, the penetration index of FG through the blood-retinal barrier was found to be twice the penetration index of F. This is not what would be expected if passive transport alone were involved. Accordingly, it is suggested that active transport mechanisms contribute to the movement of F and FG across the blood-retinal barrier.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3609757     DOI: 10.1007/bf02175445

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  17 in total

1.  Determination of fluorescein and fluorescein monoglucuronide excreted in urine.

Authors:  S C Chen; H Nakamura; Z Tamura
Journal:  Chem Pharm Bull (Tokyo)       Date:  1980-09       Impact factor: 1.645

2.  Photometric oculometry. I. An analysis of the optical principles in slit-lamp fluorophotometry.

Authors:  B Krogsaa; H Fledelius; J Larsen; H Lund-Andersen
Journal:  Acta Ophthalmol (Copenh)       Date:  1984-04

3.  Studies on the technique of vitreous fluorophotometry.

Authors:  R C Zeimer; J G Cunha-Vaz; M E Johnson
Journal:  Invest Ophthalmol Vis Sci       Date:  1982-05       Impact factor: 4.799

4.  Studies on the metabolites of fluorescein in rabbit and human urine.

Authors:  S C Chen; H Nakamura; Z Tamura
Journal:  Chem Pharm Bull (Tokyo)       Date:  1980-05       Impact factor: 1.645

5.  Early breakdown of the blood-retinal barrier in diabetes.

Authors:  J Cunha-Vaz; J R Faria de Abreu; A J Campos
Journal:  Br J Ophthalmol       Date:  1975-11       Impact factor: 4.638

6.  Measurement of blood-retinal barrier permeability: a reproducibility study in normal eyes.

Authors:  P S Chahal; P J Chowienczyk; E M Kohner
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-07       Impact factor: 4.799

7.  Lens transmission of blue-green light in diabetic patients as measured by autofluorophotometry.

Authors:  J A van Best; L Vrij; J A Oosterhuis
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-04       Impact factor: 4.799

8.  Metabolism of fluorescein after intravenous administration.

Authors:  P S Chahal; M J Neal; E M Kohner
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-05       Impact factor: 4.799

9.  Fluorescein and fluorescein glucuronide pharmacokinetics after intravenous injection.

Authors:  N P Blair; M A Evans; T S Lesar; R C Zeimer
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-07       Impact factor: 4.799

View more
  6 in total

1.  Outward permeability of the blood-retinal barrier.

Authors:  A Yoshida; S Ishiko; M Kojima
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

2.  Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy.

Authors:  M Larsen; E Hommel; H H Parving; H Lund-Andersen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

3.  Computer modeling of drug delivery to the posterior eye: effect of active transport and loss to choroidal blood flow.

Authors:  Ram K Balachandran; Victor H Barocas
Journal:  Pharm Res       Date:  2008-08-05       Impact factor: 4.200

4.  Lens fluorometry: light-attenuation effects and estimation of total lens transmittance.

Authors:  M Larsen; H Lund-Andersen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

5.  Plasma fluorescein and fluorescein glucuronide in patients with selected eye diseases.

Authors:  N P Blair; M A Evans; T S Lesar; M Willett
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

6.  Differential spectrofluorometry in the human vitreous: blood-retina barrier permeability to fluorescein and fluorescein glucuronide.

Authors:  M Larsen; P Dalgaard; H Lund-Andersen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.